Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Feb 15, 2004; 10(4): 505-508
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.505
Figure 1
Figure 1 Criteria of treatment selection.
Figure 2
Figure 2 Kaplan-Meier curves of survival rates of TACE-, LRFA- and conservatively-treated groups of patients with TMN stage II hepatocarcinomas.
Figure 3
Figure 3 Kaplan-Meier curve of recurrence rate of TACE and LRFA in TMN stage II.